A New More Efficient Cycloplegia Scheme
Overview
- Phase
- Phase 4
- Intervention
- Cyclopentolate
- Conditions
- Refractive Errors
- Sponsor
- Pontificia Universidad Catolica de Chile
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Change in Spherical equivalent
- Last Updated
- 11 years ago
Overview
Brief Summary
The purpose of this study is to determine whether tropicamide + phenylephrine cyclopentolate + applied for once waiting 30 minutes to retinoscopy (new scheme) is not inferior to apply cyclopentolate alone and wait 45 minutes to retinoscopy (traditional scheme)
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children between 1 and 10 years
Exclusion Criteria
- •Strabismus
- •Ocular surgery
- •Another ocular disease than ametropias (i.e uveitis, cataract)
- •Cardiovascular or neurologic disease.
- •Allergy to any of drugs used in the study
Arms & Interventions
Cyclopentolate
Intervention: Cyclopentolate
Cyclopentolate
Intervention: Cyclopentolate+tropicamide+phenylephrine
Cyclopentolate+tropicamide+phenylephrine
Intervention: Cyclopentolate
Cyclopentolate+tropicamide+phenylephrine
Intervention: Cyclopentolate+tropicamide+phenylephrine
Outcomes
Primary Outcomes
Change in Spherical equivalent
Time Frame: average 18 days
In the first and second visit the spherical equivalent will be measured with retinoscopy. Change in spherical equivalent refraction from first visit to day average 18 days (second visit). On both visits the patient will receive different cyclopegia schemes.
Secondary Outcomes
- Change in spherical refraction(average 18 days)
- Change in cylindrical refraction(average 18 days)
- iris motility(average 18 days)